Neurologic complications of hepatitis C

Neurologist

Volumn 14, Issue 3, 2008, Pages 151-156

  Acharya, Jayant N ^a   Pacheco, Vitor H ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroids; Cryoglobulinemia; Hepatitis C; Interferon; Myelopathy; Neuropathy; Stroke; Vasculitis

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MEPREDNISONE; PEGINTERFERON ALPHA; RIBAVIRIN; RITUXIMAB;

ANTIVIRAL THERAPY; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COGNITIVE DEFECT; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; ENCEPHALOMYELITIS; HEPATITIS C; HUMAN; NEUROLOGICAL COMPLICATION; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; STROKE; TREATMENT INDICATION; VASCULITIS;

COGNITION DISORDERS; CRYOGLOBULINEMIA; ENCEPHALOMYELITIS; HEPATITIS C; HUMANS; MYELITIS, TRANSVERSE; PERIPHERAL NERVOUS SYSTEM DISEASES; STROKE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 43449103664     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31815fa594     Document Type: Review

References (61)

1. Chen SL, Morgan TR. The natural history of hepatitis C virus HCV infection. Int J Med. 2006;3:47-52.
2. Galossi A, Guarisco R, Bellis L, et al. Extrahepatic manifestations of chronic HCV infection. J Gastrointest Liver Dis. 2007;16:65-73.
3. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995;123:615-620.
4. El-Serag HB, Hampel H, Yeh C, et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439-1445.
5. Tembl JI, Ferrer JM, Sevilla MT, et al. Neurological complications associated with hepatitis C infection. Neurology. 1999;53:861-864.
6. Khella SL, Souayah N. Hepatitis C: a review of its neurologic complications. The Neurologist. 2002;8:101-106.
7. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore). 2000;79:47-56.
8. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436-2441.
9. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
10. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-714.
11. Lunel F, Musset L. Hepatitis C virus infection and cryoglobulinemia. Forum (Geneva). 1998;8:95-103.
12. Monti G, Galli M, Invernizzi F, et al. Cryoglobulinaemias: a multicentre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC, Italian Group for the Study of Cryoglobulinaemias. Q J Med. 1995;88:15-126.
13. Parise ER, de Oliveira AC, Ferraz MC, et al. Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin. Rev Inst Med Trop Sao Paulo. 2007;49:67-72.
14. Vigani AG, Macedo-de-Oliveira A, Pavan MHP, et al. Hepatitis C virus infection, cryoglobulinemia and peripheral neuropathy: a case report. Braz J Med Biol Res. 2005;38:1729-1734.
15. Kanda T. Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinemia really important? Intern Med. 2003;42:377-378.
16. Carson CW, Conn DL, Czaja AJ, et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol. 1993;20:304-309.
17. Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol. 2001;109-118.
18. Bonetti B, Scardoni M, Monaco S, et al. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch. 1999;434:533-535.
19. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum. 1997;40:2007-2015.
20. Authier FJ, Bassez G, Payan C, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology. 2003;60:808-812.
21. Cacoub P, Saadoun D, Limal N, et al. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS. 2005;19(Suppl 3):S128-S134.
22. Maisonobe T, Leger JM, Musset L, et al. Neurological manifestations in cryoglobulinemia. Rev Neurol (Paris). 2002;158:920-924.
23. Ijichi T, Kono I, Mori S, et al. Peripheral neuropathy in Japanese patients with hepatitis C virus infection. Intern Med. 2003;42:394-399.
24. Costa J, Resende C, de Carvalho M. Motor-axonal polyneuropathy associated with hepatitis C virus. Eur J Neurol. 2003;10:183-185.
25. Nemni R, Sanvito L, Quattrini A, et al. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003;74:1267-1271.
26. Santoro L, Manganelli F, Briani C, et al. ; HCV Peripheral Nerve Study Group. Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population. J Neurol Neurosurg Psychiatry. 2006;77:626-629.
27. Ripault MP, Borderie C, Dumas P, et al. Peripheral neuropathies and chronic hepatitis C: a frequent association? Gastroenterol Clin Biol. 1998;22:81-896.
28. Boukhris S, Magy L, Senga-mokono U, et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol. 2006;13:937-941.
29. Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2002;25:909-913.
30. Lidove O, Cacoub P, Hausfater P, et al. Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon [alpha] treatment. Gastroenterol Clin Biol. 1999;23:403-406.
31. Briani C, Chemello L, Zara G, et al. Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. Neurology. 2006;67:781-785.
32. Levy Y, Uziel Y, Zandman G, et al. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann NY Acad Sci. 2005;1051:779-786.
33. Sansonno D, De Re V, Lauletta G, et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon with an anti-CD20. Blood. 2003;101:3818-3826.
34. Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827-3834.
35. Cai FZ, Ahern M, Smith M. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol. 2006;33:1197-1198.
36. Petty GW, Duffy J, Houston J III. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc. 1996;71:671-678.
37. Origgi L, Vanoli M, Carbone A, et al. Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am J Med Sci. 1998;315:208-210.
38. Cacoub P, Sbai A, Hausfater P, et al. Central nervous system involvement in hepatitis C virus infection. Gastroenterol Clin Biol. 1998;22:631-633.
39. Aiba T, Watanabe T, Kolke T, et al. C-type hepatitis in spontaneous intracerebral hemorrhage. No To Shinkei. 1996;48:1116-1119.
40. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow up of 40 patients. Am J Med. 1980;69:287-308.
41. Dawson TM, Starkebaum G. Isolated central nervous system vasculitis associated with hepatitis C infection. J Rheumatol. 1999;26:2273-2276.
42. Propst T, Nachbauer K, Graziadei I, et al. Papillitis and vasculitis of the arteria spinalis anterior as complications of hepatitis C reinfection after liver transplantation. Transpl Int. 1997;10:234-237.
43. Cojocaru IM, Cojocaru M, Iacob SA. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke. Rom J Intern Med. 2005;43:89-95.
44. Rafai MA, Fadel H, Gam I, et al. Recurrent stroke revealing catastrophic antiphospholipid syndrome with hepatitis C infection. Rev Neurol (Paris). 2006;162:1131-1134.
45. Morsica G, Bernardi MT, Novati R, et al. Detection of hepatitis C genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol. 197;53:252-254.
46. Nolte CH, Endres AS, Meisel H. Sensory ataxia in myelopathy with chronic hepatitis C viral infection. Neurology. 2002;59:958.
47. Zandman-Goddard G, Levy Y, Weiss P, et al. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol 2003;21:111-113.
48. Grewal AK, Lopes MB, Berg CL, et al. Recurrence demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci. 2004;224:101-106.
49. Pacheco VH, Acharya JN. Recurrent transverse myelopathy associated with hepatitis C. Ann Neurol 2006;60(Suppl 3):S45.
50. Aktipi KM, Ravaglia S, Ceroni M, et al. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology. 2007;68:468-469.
51. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485-1489.
52. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. NMO IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;566-569.
53. Laskus T, Radkowski M, Bednarska A, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002;10064-10068.
54. Forton DM, Allsop JM, Main J, et al. Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001;358:38-39.
55. Casato M, Saadoun D, Marchetti A, et al. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol. 2005;32:484-488.
56. McAndrews MP, Farcnik K, Carlen P, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology. 2005;41:801-808.
57. Forton D, Thomas HC, Taylor-Robinson. Central nervous system involvement in hepatitis C virus infection. Metab Brain Dis. 2004;19:383-391.
58. Radkowski M, Wilkinson J, Nowicki M, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002;76:600-608.
59. Forton DM, Karayiannis P, Mahmud N, et al. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver and serum variants. J Virol. 2004;5170-5183.
60. Bolay H, Soylemezoglu G, Nurlu G, et al. PCR detected hepatitis C virus genome in the brain of a case with progressive myelitis with rigidity. Clin Neurol Neurosurg. 1996;98:305-308.
61. Sacconi S, Salviati L, Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol. 2001;58:1679-1681.